SUBSTITUTED ARYLAMINE COMPOUNDS, SUBSTITUTED HETEROARYLAMINE COMPOUNDS, AND METHODS USING SAME

The present disclosure relates to substituted arylamine and substituted heteroarylamine compounds, analogues thereof, and compositions comprising the same. In one aspect, the compounds contemplated in the disclosure can be used to treat, ameliorate, and/or prevent hepatitis B virus (HBV) and/or hepa...

Full description

Saved in:
Bibliographic Details
Main Authors COLE, Andrew G, SOFIA, Michael J, HEFFERNAN, Gavin D, OZTURK, Seyma, QUINTERO, Jorge G, FAN, Yi
Format Patent
LanguageEnglish
French
Published 27.06.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to substituted arylamine and substituted heteroarylamine compounds, analogues thereof, and compositions comprising the same. In one aspect, the compounds contemplated in the disclosure can be used to treat, ameliorate, and/or prevent hepatitis B virus (HBV) and/or hepatitis D virus (HDV) infections in a patient. In another aspect, the compounds contemplated in the disclosure can be used to treat, ameliorate, and/or prevent cancer in a patient. La présente divulgation concerne des composés d'arylamine substitués et d'hétéroarylamine substitués, des analogues de ceux-ci et des compositions les comprenant. Selon un aspect, les composés décrits dans la divulgation peuvent être utilisés pour traiter, atténuer et/ou prévenir des infections par le virus de l'hépatite B (VHB) et/ou le virus de l'hépatite D (VHD) chez un patient. Selon un autre aspect, les composés décrits dans la divulgation peuvent être utilisés pour traiter, atténuer et/ou prévenir le cancer chez un patient.
Bibliography:Application Number: WO2023IB62889